Amyloid-β peptide (Aβ) and tau protein deposits in the human brain are the pathological hallmarks of Alzheimer's disease (AD). Tau is a class of proteins that are abundant in nerve cells and perform the function of stabilizing microtubules. However, in certain pathological situations, Tau proteins become defective and fail to adequately stabilize microtubules, which can result in the generation of abnormal masses that are toxic to neurons. This process occurs in a number of neurological disorders collectively known as Tauopathies. Tau protein is the major factor of the intracellular fi lamentous deposits that relate to a number of neurodegenerative diseases which includes the progressive supranuclear palsy (PSP), Pick's disease, and Parkinsonism. The identifi cation of mutations in Tau established that dysfunction or misregulation of tau protein is suffi cient to cause dementia and neurodegeneration. In this review article, we discussed the etiology of the tau formation and role in AD and subsequently therapeutic approach for disassembling and Tau inhibition.
CITATION STYLE
Bhaskar C, D. (2018). The Role of Tau Protein in Diseases. Annals of Advances in Chemistry, 001–016. https://doi.org/10.29328/journal.aac.1001010
Mendeley helps you to discover research relevant for your work.